Keyphrases
Inhibitor Treatment
100%
Influenza-like Illness
100%
Influenza Virus Inhibitors
100%
Polymerase Basic Protein 2
100%
Pimodivir
100%
P-glycoprotein (P-gp)
50%
Phase III Clinical Trial
25%
Adverse Events
25%
Inhibitory Effect
25%
Dose Effect
25%
Polymerase
25%
Clinical Development
25%
Diarrhea
25%
Inhibitor Resistant
25%
Influenza Virus
25%
Resistant Strains
25%
Binding Activity
25%
Twice Daily
25%
Drug Interactions
25%
Nucleoside Analogues
25%
Influenza A
25%
Unnatural nucleotides
25%
Virus Load
25%
Virus Polymerase
25%
Isoenzymes
25%
Neuraminidase Inhibitors
25%
Adamantane
25%
Anti-influenza Drug
25%
OATP1B1
25%
CYP3A4 Metabolism
25%
Induction Effect
25%
Cap-binding
25%
VX-787
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Influenza A
100%
Influenza Virus
100%
Basic Protein
100%
Pimodivir
100%
P-Glycoprotein
50%
Influenza A Virus
50%
Clinical Trial
25%
Virus Infection
25%
Adverse Event
25%
Drug Interaction
25%
Diarrhea
25%
CYP3A4
25%
Sialidase Inhibitor
25%
Adamantane
25%
Isoenzyme
25%
Nucleoside Analog
25%